Actinium Pharmaceuticals reported $266K in Sales Revenues for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US $ 13959M 949M
Actinium Pharmaceuticals ATNM:US $ 266K 356K
Amgen AMGN:US $ 6526M 625M
Capricor Therapeutics CAPR:US $ 0.2M 0.16M
Immunogen IMGN:US $ 16.95M 1.24M
Pfizer PFE:US $ 18977M 4395M
Seattle Genetics SGEN:US $ 388.48M 56.5M